Active Ingredient(s): Somatrem, Recombinant, rh-GH
FDA Approved: * October 17, 1985
Pharm Company: * GENENTECH
Category: Growth Hormone Treatment

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Protropin Overview

Somatrem, sold under the brand name Protropin, is an analogue of growth hormone (GH).[1] Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone. Somatrem was first marketed under the brand name Protropin by Genentech in 1985.[2] It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus[3][circular ref...

Read more Protropin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Protropin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Somatrem, Recombinant, rh-GH
  • Injection: 10mg, 10mg/vial, 5mg, 5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Somatrem, Recombinant, rh-GH or a similar ingredient: (1 result)